Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study)

Maki Ishii, Ikuko Hirai, Keiji Tanese, Takayuki Fusumae, Yoshio Nakamura, Keitaro Fukuda, Hiroshi Uchi, Kenji Kabashima, Atsushi Otsuka, Kenji Yokota, Naoya Yamazaki, Kenjiro Namikawa, Taku Fujimura, Tatsuya Takenouchi, Yuki Yamamoto, Mana Nishiguchi, Yasunori Sato, Masayuki Amagai, Takeru Funakoshi

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study)'. Together they form a unique fingerprint.

Medicine & Life Sciences